Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
unknown
📅 Published: 2026-03-19 08:25
📰 Source: Benzinga
📝 Words: 17
📝 Article Content
FDA approves Icotyde, a once-daily psoriasis pill from Johnson & Johnson, sparking new competition in treatment options.
📄 Summary
FDA approves Icotyde, a once-daily psoriasis pill from Johnson & Johnson, sparking new competition in treatment options.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-03-20 04:09:39
Updated At:
2026-03-20 04:09:39
Scraping Job ID:
N/A
Stock Mentions:
AMP - Ameriprise Financial Inc.
Relevance: N/A